Genedata Expressionist Delivers Robust New Peak Detection Enabling MS-based MAM in QC
Summary
Developed in close collaboration with industry-leading partners, the robust, efficient, and user-friendly NPD workflow in Genedata Expressionist leverages automatic artifact detection and a sequential filtering strategy to practically eliminate false positives across large datasets. Automated workflows detect new, changing, and absent species with unmatched precision and speed, while intuitive visualizations provide users with a complete analysis overview and facilitate result evaluation for non-MS experts. "With Genedata Expressionist, organizations can now make informed decisions across the global biopharma network, from R&D to regulated environments, based on in-depth product and process understanding." Genedata Expressionist consolidates its leading position in intact mass capabilities for impurity analysis and introduces identification based on MS/MS fragment spectra mapping, which is essential for detecting sequence variants and chemical modifications during oligonucleotide synthesis. Trusted by leading biopharmaceutical companies worldwide, Genedata Expressionist continues to streamline biopharma workflows across organizations to deliver high-quality results with significant time and cost savings due to automating and harmonizing all MS data processes.
Classifications
AskAI Classifications
LabelsLinked Companies
